Impact of ideal vs actual body weight on analgesic and sedative requirements in critically ill patients with obesity
Clicks: 2
ID: 316503
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
0.3
/100
2 views
1 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #96 of 143 articles by views in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 143 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
PURPOSE: Analgosedation is the standard of care for managing mechanically ventilated critically ill patients. Most sedative medications are lipophilic, with increased volume of distribution in patients with obesity; however, data about dosing these drugs in critically ill patients with obesity are limited. In 2022, our institution changed to an ideal body weight (IBW) dosing strategy for all weight-based continuous infusions of analgesia and sedation agents, including fentanyl, ketamine, propofol, and dexmedetomidine. This study evaluated whether utilizing IBW dosing for critically ill patients with obesity results in decreased analgesic requirements. METHODS: This was a single-center, retrospective, observational cohort study that included critically ill adult patients with a body mass index (BMI) of greater than 30 kg/m2 receiving analgosedation with continuous fentanyl from January 1 to March 31, 2020 (actual body weight [ABW] group) and from January 1 to March 31, 2024 (IBW group). Patients were excluded if they required deep sedation or mechanical circulatory support, had a history of chronic opioid use or opioid use disorder, or had a positive COVID-19 result. The primary outcome was cumulative morphine milligram equivalent (MME) requirements during the fentanyl continuous infusion. Secondary outcomes included the cumulative doses of sedation and duration of mechanical ventilation, as well as intensive care unit (ICU) and hospital length of stay (LOS). Efficacy was evaluated via RASS and CPOT score and by as-needed opioid and benzodiazepine requirements in MME and midazolam equivalents. RESULTS: Forty-six patients in the ABW group and 31 patients in the IBW group were included. The median BMI was similar (ABW group, 35.3 kg/m2; IBW group, 34.9 kg/m2; P = 0.83). The IBW group had significantly lower median cumulative intravenous MME requirements (ABW group, 931.2 mg; IBW group, 537.9 mg; P = 0.04). For the secondary outcomes, the cumulative MME requirements for fentanyl differed between the dosing strategies (ABW group, 914.1; IBW group, 485.8; P = 0.03), but no differences were found for other sedatives, as-needed opioids or benzodiazepines, duration of mechanical ventilation, ICU LOS, or hospital LOS. CONCLUSION: Utilizing IBW dosing decreased cumulative opioid requirements in critically ill patients with obesity without resulting in increased doses of other sedatives or as-needed medications.
| Reference Key |
openalex_W7164003478
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Melanie Datt, Ashley Taylor, Christy Forehand, Emma Pearman, Allison Lopez, Brooke A. Smith |
| Journal | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists |
| Year | 2026 |
| DOI |
10.1093/ajhp/zxag159
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.